Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
695,981
-
Share change
-
+9,217
-
Total reported value
-
$1,709,524
-
Price per share
-
$2.46
-
Number of holders
-
15
-
Value change
-
+$22,671
-
Number of buys
-
8
-
Number of sells
-
6
Institutional Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q4 2022
As of 31 Dec 2022,
Lexaria Bioscience Corp. - COM NEW (LEXX) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
695,981 shares.
The largest 10 holders included
Invenomic Capital Management LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, Centiva Capital, LP, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, and Tower Research Capital LLC (TRC).
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.